ELITE TEST BANK:
MEDICAL-SURGICAL NURSING
(2026/2027 STANDARDS)
PART I: THE PRIMER
Mastering medical-surgical nursing separates task-oriented novices from clinical grandmasters
capable of anticipating and averting physiological collapse. In the 2026/2027 healthcare
environment, this expertise remains the definitive baseline for autonomous, high-acuity patient
rescue and systems-level safety.
The "Panic Button" Cheat Sheet:
● ISMP 2026: Vinca alkaloids must strictly be administered intravenously via minibag
dilution; intrathecal administration is 100% fatal.
● SSC Hour-1 Bundle (2026): Initiate 30 mL/kg balanced crystalloids and broad-spectrum
antimicrobials within exactly 60 minutes of sepsis recognition for a lactate ≥ 4 mmol/L.
● AHA Stroke (2026): Tenecteplase 0.25 mg/kg IV bolus is the preferred primary
reperfusion agent over alteplase within the 4.5-hour window.
● ADA (2026): GLP-1 receptor agonists are frontline for the Cardio-Renal-Metabolic
framework; Continuous Glucose Monitoring (CGM) is the mandatory baseline.
● Joint Commission NPG 12 (2026): Competency-based nurse staffing alignment is a
mandatory clinical safety standard.
PART II: THE ELITE TEST BANK
Questions 1–15: Foundational Syntax & Application
Q1: The practitioner is preparing a patient for elective bowel resection. The patient is
prescribed a weekly glucagon-like peptide-1 (GLP-1) receptor agonist for Type 2 Diabetes
Mellitus. According to 2026 American Society of Anesthesiologists (ASA) guidelines,
what is the mandatory preoperative protocol? A) Administer the medication on schedule to
prevent perioperative hyperglycemia. B) Hold the medication exactly 24 hours prior to the
induction of anesthesia. C) Withhold the weekly dose for one full week prior to the procedure to
prevent aspiration. D) Continue the medication but administer a prokinetic agent to enhance
bowel motility.
● The Answer: C (Withhold the weekly dose for one full week prior to the procedure to
prevent aspiration.)
● Distractor Analysis: Option A guarantees a high risk of regurgitation due to delayed
gastric emptying. Option B applies strictly to daily-dosed GLP-1 agents, not weekly
formulations. Option D is an amateur trap; prokinetic agents cannot reliably override the
profound vagal suppression caused by GLP-1 agonists during deep sedation or general
anesthesia.
, ● The Mentor's Analysis: GLP-1 receptor agonists inherently induce delayed gastric
emptying to promote satiety. The 2026/2027 ASA standards definitively recognize this as
a severe pulmonary aspiration risk. The clinical hard deck requires pausing weekly
formulations for one week to allow gastric motility to normalize, bridging with
endocrinology-approved alternative glycemic control if necessary.
Q2: According to the 2026/2027 Institute for Safe Medication Practices (ISMP) Targeted
Medication Safety Best Practices, which action is strictly prohibited when managing
high-alert weight-based medications? A) Utilizing purely metric units (kilograms) for all
electronic health record documentation. B) Converting a stated weight in pounds to kilograms
utilizing a dual-display clinical scale. C) Prompting the patient to state their weight exclusively in
metric units upon admission. D) Locking out the ability of the clinical scale to measure in pounds
entirely.
● The Answer: B (Converting a stated weight in pounds to kilograms utilizing a dual-display
clinical scale.)
● Distractor Analysis: Options A and D represent the exact compliance standards
mandated by ISMP. Option C is clinically appropriate if relying on stated weight in an
emergency. Option B is a catastrophic error; dual-display scales induce reading errors
that result in massive pediatric or narrow-therapeutic-index overdoses.
● The Mentor's Analysis: Weight measurement in the 2026 clinical landscape is
exclusively metric. ISMP mandates that scales must measure only in kilograms and be
technologically locked to prevent toggling to pounds. Relying on manual conversions from
pounds introduces human mathematical error, an unacceptable vulnerability when
calculating highly toxic, narrow-therapeutic-index drugs.
ISMP 2026 Metric Weight Mandates Implementation Strategy
Scale Hardware Must be locked to kilograms (kg) exclusively;
disable lbs/oz functionality.
EHR Documentation Electronic health records must only prompt for
and accept metric weight values.
Patient Communication Utilize conversion charts near scales to inform
patients of their weight in pounds if requested,
without altering the raw clinical data.
Q3: A patient presenting with an Acute Ischemic Stroke (AIS) at 2.5 hours post-symptom
onset is selected for intravenous thrombolysis. According to 2026 American Heart
Association (AHA) stroke guidelines, what is the precise dosing strategy for the preferred
agent? A) Alteplase 0.9 mg/kg delivered as a 10% bolus followed by a 60-minute continuous
infusion. B) Tenecteplase 0.40 mg/kg administered as a continuous infusion over 30 minutes. C)
Tenecteplase 0.25 mg/kg administered as a rapid, single intravenous bolus over 5-10 seconds.
D) Alteplase 0.50 mg/kg delivered as an immediate intravenous push.
● The Answer: C (Tenecteplase 0.25 mg/kg administered as a rapid, single intravenous
bolus over 5-10 seconds.)
● Distractor Analysis: Option A is the obsolete standard protocol; while permissible, it is
no longer the preferred agent. Option B utilizes a toxic 0.40 mg/kg dose which is explicitly
contraindicated due to heightened intracranial hemorrhage risk. Option D relies on
incorrect dosing syntax entirely.
● The Mentor's Analysis: Tenecteplase (TNK) at 0.25 mg/kg (maximum 25 mg) is the
2026 premier standard for AIS within the 4.5-hour window. It boasts superior fibrin
specificity, a longer half-life, and eliminates the 60-minute infusion pump requirement
, associated with alteplase, thereby drastically reducing door-to-needle times and nursing
administration errors.
Q4: Under the 2026 Joint Commission National Performance Goal (NPG) 12, how must
the nursing leadership structurally execute shift assignments for a high-acuity
medical-surgical unit? A) Assigning patients strictly based on equal numerical distribution to
ensure workload fairness. B) Aligning staff assignments dynamically based on validated,
data-driven competency and patient acuity. C) Utilizing the chronological seniority of the
registered nurse to distribute the highest acuity cases. D) Delegating all standard assessments
to unlicensed assistive personnel to free up registered nurses.
● The Answer: B (Aligning staff assignments dynamically based on validated, data-driven
competency and patient acuity.)
● Distractor Analysis: Option A ignores the physiological complexity of the patient, a fatal
flaw in high-acuity settings. Option C relies on tenure rather than verifiable clinical skill.
Option D violates the scope of practice; unlicensed personnel cannot perform initial or
high-acuity assessments.
● The Mentor's Analysis: NPG 12 fundamentally shifted staffing from an operational
headcount to a mandatory safety and quality metric. The 2026 requirement demands that
nursing assignments be matched precisely to the validated competencies of the clinician
against the real-time physiological demands (acuity) of the patient. Staffing is now legally
tied directly to clinical outcomes.
Q5: The practitioner is preparing an intravenous push of labetalol for a patient in
hypertensive crisis. According to the 2026/2027 ISMP Targeted Medication Safety Best
Practices, what is the absolute requirement for preparation? A) Dilute the concentrated
medication in a 10 mL prefilled 0.9% sodium chloride flush syringe to ease administration. B)
Utilize a ready-to-administer syringe or pharmacy-compounded dilution exclusively. C)
Reconstitute the drug using sterile water within a non-labeled 5 mL generic syringe. D) Rapidly
administer the concentrated vial to bypass the need for any dilution protocols.
● The Answer: B (Utilize a ready-to-administer syringe or pharmacy-compounded dilution
exclusively.)
● Distractor Analysis: Option A is a direct violation of the ISMP 2026 redline; diluting in
flush syringes causes catastrophic mislabeling and concentration errors. Option C
introduces a high risk for swapping medications. Option D causes severe vascular
necrosis and unpredictable hemodynamic collapse.
● The Mentor's Analysis: ISMP mandates the elimination of floor-level dilution of IV push
medications using standard prefilled saline syringes. This amateur practice bypasses
essential labeling and barcoding safeguards. Master clinicians rely exclusively on
pharmacy-prepared, ready-to-administer doses to ensure exact concentration and
verifiable scanning compliance prior to administration.
Q6: A patient with Chronic Obstructive Pulmonary Disease (COPD) returns to the clinic
following a single moderate exacerbation that required oral corticosteroids last month.
Under the 2026 GOLD strategy, what is the required clinical intervention? A) Maintain the
patient on a short-acting bronchodilator as needed. B) Reclassify the patient to GOLD Group A
and continue observation. C) Reclassify the patient to GOLD Group E and initiate a
LABA+LAMA combination therapy. D) Prescribe a daily prophylactic oral antibiotic to prevent
future bacterial infections.
● The Answer: C (Reclassify the patient to GOLD Group E and initiate a LABA+LAMA
combination therapy.)
● Distractor Analysis: Options A and B ignore the severity of the exacerbation history;
MEDICAL-SURGICAL NURSING
(2026/2027 STANDARDS)
PART I: THE PRIMER
Mastering medical-surgical nursing separates task-oriented novices from clinical grandmasters
capable of anticipating and averting physiological collapse. In the 2026/2027 healthcare
environment, this expertise remains the definitive baseline for autonomous, high-acuity patient
rescue and systems-level safety.
The "Panic Button" Cheat Sheet:
● ISMP 2026: Vinca alkaloids must strictly be administered intravenously via minibag
dilution; intrathecal administration is 100% fatal.
● SSC Hour-1 Bundle (2026): Initiate 30 mL/kg balanced crystalloids and broad-spectrum
antimicrobials within exactly 60 minutes of sepsis recognition for a lactate ≥ 4 mmol/L.
● AHA Stroke (2026): Tenecteplase 0.25 mg/kg IV bolus is the preferred primary
reperfusion agent over alteplase within the 4.5-hour window.
● ADA (2026): GLP-1 receptor agonists are frontline for the Cardio-Renal-Metabolic
framework; Continuous Glucose Monitoring (CGM) is the mandatory baseline.
● Joint Commission NPG 12 (2026): Competency-based nurse staffing alignment is a
mandatory clinical safety standard.
PART II: THE ELITE TEST BANK
Questions 1–15: Foundational Syntax & Application
Q1: The practitioner is preparing a patient for elective bowel resection. The patient is
prescribed a weekly glucagon-like peptide-1 (GLP-1) receptor agonist for Type 2 Diabetes
Mellitus. According to 2026 American Society of Anesthesiologists (ASA) guidelines,
what is the mandatory preoperative protocol? A) Administer the medication on schedule to
prevent perioperative hyperglycemia. B) Hold the medication exactly 24 hours prior to the
induction of anesthesia. C) Withhold the weekly dose for one full week prior to the procedure to
prevent aspiration. D) Continue the medication but administer a prokinetic agent to enhance
bowel motility.
● The Answer: C (Withhold the weekly dose for one full week prior to the procedure to
prevent aspiration.)
● Distractor Analysis: Option A guarantees a high risk of regurgitation due to delayed
gastric emptying. Option B applies strictly to daily-dosed GLP-1 agents, not weekly
formulations. Option D is an amateur trap; prokinetic agents cannot reliably override the
profound vagal suppression caused by GLP-1 agonists during deep sedation or general
anesthesia.
, ● The Mentor's Analysis: GLP-1 receptor agonists inherently induce delayed gastric
emptying to promote satiety. The 2026/2027 ASA standards definitively recognize this as
a severe pulmonary aspiration risk. The clinical hard deck requires pausing weekly
formulations for one week to allow gastric motility to normalize, bridging with
endocrinology-approved alternative glycemic control if necessary.
Q2: According to the 2026/2027 Institute for Safe Medication Practices (ISMP) Targeted
Medication Safety Best Practices, which action is strictly prohibited when managing
high-alert weight-based medications? A) Utilizing purely metric units (kilograms) for all
electronic health record documentation. B) Converting a stated weight in pounds to kilograms
utilizing a dual-display clinical scale. C) Prompting the patient to state their weight exclusively in
metric units upon admission. D) Locking out the ability of the clinical scale to measure in pounds
entirely.
● The Answer: B (Converting a stated weight in pounds to kilograms utilizing a dual-display
clinical scale.)
● Distractor Analysis: Options A and D represent the exact compliance standards
mandated by ISMP. Option C is clinically appropriate if relying on stated weight in an
emergency. Option B is a catastrophic error; dual-display scales induce reading errors
that result in massive pediatric or narrow-therapeutic-index overdoses.
● The Mentor's Analysis: Weight measurement in the 2026 clinical landscape is
exclusively metric. ISMP mandates that scales must measure only in kilograms and be
technologically locked to prevent toggling to pounds. Relying on manual conversions from
pounds introduces human mathematical error, an unacceptable vulnerability when
calculating highly toxic, narrow-therapeutic-index drugs.
ISMP 2026 Metric Weight Mandates Implementation Strategy
Scale Hardware Must be locked to kilograms (kg) exclusively;
disable lbs/oz functionality.
EHR Documentation Electronic health records must only prompt for
and accept metric weight values.
Patient Communication Utilize conversion charts near scales to inform
patients of their weight in pounds if requested,
without altering the raw clinical data.
Q3: A patient presenting with an Acute Ischemic Stroke (AIS) at 2.5 hours post-symptom
onset is selected for intravenous thrombolysis. According to 2026 American Heart
Association (AHA) stroke guidelines, what is the precise dosing strategy for the preferred
agent? A) Alteplase 0.9 mg/kg delivered as a 10% bolus followed by a 60-minute continuous
infusion. B) Tenecteplase 0.40 mg/kg administered as a continuous infusion over 30 minutes. C)
Tenecteplase 0.25 mg/kg administered as a rapid, single intravenous bolus over 5-10 seconds.
D) Alteplase 0.50 mg/kg delivered as an immediate intravenous push.
● The Answer: C (Tenecteplase 0.25 mg/kg administered as a rapid, single intravenous
bolus over 5-10 seconds.)
● Distractor Analysis: Option A is the obsolete standard protocol; while permissible, it is
no longer the preferred agent. Option B utilizes a toxic 0.40 mg/kg dose which is explicitly
contraindicated due to heightened intracranial hemorrhage risk. Option D relies on
incorrect dosing syntax entirely.
● The Mentor's Analysis: Tenecteplase (TNK) at 0.25 mg/kg (maximum 25 mg) is the
2026 premier standard for AIS within the 4.5-hour window. It boasts superior fibrin
specificity, a longer half-life, and eliminates the 60-minute infusion pump requirement
, associated with alteplase, thereby drastically reducing door-to-needle times and nursing
administration errors.
Q4: Under the 2026 Joint Commission National Performance Goal (NPG) 12, how must
the nursing leadership structurally execute shift assignments for a high-acuity
medical-surgical unit? A) Assigning patients strictly based on equal numerical distribution to
ensure workload fairness. B) Aligning staff assignments dynamically based on validated,
data-driven competency and patient acuity. C) Utilizing the chronological seniority of the
registered nurse to distribute the highest acuity cases. D) Delegating all standard assessments
to unlicensed assistive personnel to free up registered nurses.
● The Answer: B (Aligning staff assignments dynamically based on validated, data-driven
competency and patient acuity.)
● Distractor Analysis: Option A ignores the physiological complexity of the patient, a fatal
flaw in high-acuity settings. Option C relies on tenure rather than verifiable clinical skill.
Option D violates the scope of practice; unlicensed personnel cannot perform initial or
high-acuity assessments.
● The Mentor's Analysis: NPG 12 fundamentally shifted staffing from an operational
headcount to a mandatory safety and quality metric. The 2026 requirement demands that
nursing assignments be matched precisely to the validated competencies of the clinician
against the real-time physiological demands (acuity) of the patient. Staffing is now legally
tied directly to clinical outcomes.
Q5: The practitioner is preparing an intravenous push of labetalol for a patient in
hypertensive crisis. According to the 2026/2027 ISMP Targeted Medication Safety Best
Practices, what is the absolute requirement for preparation? A) Dilute the concentrated
medication in a 10 mL prefilled 0.9% sodium chloride flush syringe to ease administration. B)
Utilize a ready-to-administer syringe or pharmacy-compounded dilution exclusively. C)
Reconstitute the drug using sterile water within a non-labeled 5 mL generic syringe. D) Rapidly
administer the concentrated vial to bypass the need for any dilution protocols.
● The Answer: B (Utilize a ready-to-administer syringe or pharmacy-compounded dilution
exclusively.)
● Distractor Analysis: Option A is a direct violation of the ISMP 2026 redline; diluting in
flush syringes causes catastrophic mislabeling and concentration errors. Option C
introduces a high risk for swapping medications. Option D causes severe vascular
necrosis and unpredictable hemodynamic collapse.
● The Mentor's Analysis: ISMP mandates the elimination of floor-level dilution of IV push
medications using standard prefilled saline syringes. This amateur practice bypasses
essential labeling and barcoding safeguards. Master clinicians rely exclusively on
pharmacy-prepared, ready-to-administer doses to ensure exact concentration and
verifiable scanning compliance prior to administration.
Q6: A patient with Chronic Obstructive Pulmonary Disease (COPD) returns to the clinic
following a single moderate exacerbation that required oral corticosteroids last month.
Under the 2026 GOLD strategy, what is the required clinical intervention? A) Maintain the
patient on a short-acting bronchodilator as needed. B) Reclassify the patient to GOLD Group A
and continue observation. C) Reclassify the patient to GOLD Group E and initiate a
LABA+LAMA combination therapy. D) Prescribe a daily prophylactic oral antibiotic to prevent
future bacterial infections.
● The Answer: C (Reclassify the patient to GOLD Group E and initiate a LABA+LAMA
combination therapy.)
● Distractor Analysis: Options A and B ignore the severity of the exacerbation history;
